13F filer · CIK 2012383 ↗
BlackRock
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$3.19T
+8.5% on the quarter before
Positions
5,765
230 new · 334 sold out
Top 10
17.2%
of the value
Est. gain
+$207.61B
on stocks held all quarter
Est. return
+7.2%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from BlackRock's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$3.17BAdded · 4.1% → 4.0%+13,199,032 shares
- Ishares Tr~$2.02BAdded · 0.8% → 0.9%+5,252,412 shares
- Prologis~$1.81BAdded · 0.3% → 0.3%+16,093,126 shares
- Unitedhealth Group Inc~$1.63BAdded · 1.2% → 1.2%+3,072,282 shares
- Home Depot Inc~$1.51BAdded · 0.7% → 0.8%+4,783,139 shares
- Apple~$1.16BAdded · 4.8% → 4.2%+8,963,137 shares
- Exxon Mobil Corp~$1.14BAdded · 0.8% → 1.0%+10,367,104 shares
- Amazon~$1.06BAdded · 2.2% → 1.6%+12,593,415 shares
- Chevron Corp New~$971.8MAdded · 0.6% → 0.8%+5,414,138 shares
- Ferguson Plc New~$962.6MAdded · 0.0% → 0.0%+7,581,255 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$3.44BCut · 0.1% → 0.0%−8,995,800 underlying
- Twitter Inc~$2.05BSold out · 0.1% → 0.0%−46,738,155 shares
- Duke Realty Corp~$1.63BSold out · 0.1% → 0.0%−33,908,472 shares
- SPDR S&P 500 ETF TrCALL~$1.45BCut · 0.1% → 0.0%−3,800,600 underlying
- Citrix Sys Inc~$1.29BSold out · 0.0% → 0.0%−12,438,524 shares
- Abiomed Inc~$1.12BSold out · 0.0% → 0.0%−4,560,483 shares
- Alleghany Corp Md~$1.07BSold out · 0.0% → 0.0%−1,275,740 shares
- Ishares Tr~$1.06BCut · 0.2% → 0.1%−16,184,905 shares
- Invesco Qqq TrCALL~$902.4MCut · 0.0% → 0.0%−3,389,000 underlying
- S&P Global Inc~$871.4MCut · 0.3% → 0.3%−2,601,512 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.9% · price −6.0% | 4.2% | $133.73B | −$8.44B | ||||||||
| MicrosoftCOM · shares +2.5% · price +3.0% | 4.0% | $127.59B | +$3.59B | ||||||||
| AmazonCOM · shares +2.2% · price −25.7% | 1.6% | $49.96B | −$16.88B | ||||||||
| Unitedhealth Group IncCOM · shares +4.3% · price +5.0% | 1.2% | $39.46B | +$1.79B | ||||||||
| AlphabetCAP STK CL A · shares +1.1% · price −7.8% | 1.1% | $36.70B | −$3.05B | ||||||||
| Johnson & JohnsonCOM · shares −0.5% · price +8.1% | 1.1% | $35.12B | +$2.64B | ||||||||
| AlphabetCAP STK CL C · shares +0.03% · price −7.7% | 1.0% | $32.36B | −$2.71B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +0.8% · price +15.7% | 1.0% | $32.30B | +$4.34B | ||||||||
| Exxon Mobil CorpCOM · shares +3.7% · price +26.3% | 1.0% | $32.12B | +$6.46B | ||||||||
| Ishares TrCORE S&P500 ETF · shares +7.7% · price +7.1% | 0.89% | $28.26B | +$1.75B | ||||||||
| NvidiaCOM · shares +1.9% · price +20.4% | 0.82% | $26.28B | +$4.37B | ||||||||
| Jpmorgan Chase & CoCOM · shares −1.5% · price +28.3% | 0.82% | $26.14B | +$5.77B | ||||||||
| Visa Inc.COM CL A · shares +1.5% · price +16.9% | 0.81% | $25.95B | +$3.70B | ||||||||
| Chevron Corp NewCOM · shares +4.2% · price +24.9% | 0.76% | $24.29B | +$4.65B | ||||||||
| Procter And Gamble CoCOM · shares −1.4% · price +20.0% | 0.76% | $24.20B | +$4.04B | ||||||||
| Home Depot IncCOM · shares +6.7% · price +14.5% | 0.75% | $24.09B | +$2.85B | ||||||||
| Merck & Co IncCOM · shares +0.1% · price +28.8% | 0.75% | $23.82B | +$5.33B | ||||||||
| Eli LillyCOM · shares +2.7% · price +13.1% | 0.75% | $23.81B | +$2.69B | ||||||||
| Pfizer IncCOM · shares +2.4% · price +17.1% | 0.71% | $22.69B | +$3.24B | ||||||||
| MastercardCL A · shares +1.0% · price +22.3% | 0.70% | $22.46B | +$4.06B | ||||||||
| Abbvie IncCOM · shares +4.3% · price +20.4% | 0.70% | $22.42B | +$3.64B | ||||||||
| TeslaCOM · shares +3.4% · price −53.6% | 0.69% | $21.89B | −$24.42B | ||||||||
| Pepsico IncCOM · shares +3.2% · price +10.7% | 0.62% | $19.90B | +$1.86B | ||||||||
| Coca Cola CoCOM · shares +3.0% · price +13.5% | 0.62% | $19.78B | +$2.29B | ||||||||
| MetaCL A · shares +0.7% · price −11.3% | 0.57% | $18.26B | −$2.31B | ||||||||
| Total · 5,765 positions | 100% | $3.19T | +$207.61B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 5,190 stocks held throughout, up $207.61B (+7.2%).
- Exxon Mobil Corp+$6.46B+26%
- Jpmorgan Chase & Co+$5.77B+28%
- Merck & Co Inc+$5.33B+29%
- Chevron Corp New+$4.65B+25%
- Nvidia+$4.37B+20%
- Alphabet−$2.71B−8%
- Alphabet−$3.05B−8%
- Apple−$8.44B−6%
- Amazon−$16.88B−26%
- Tesla−$24.42B−54%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 10 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $6.73T+18% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $5.72T−3% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $5.92T+4% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $5.71T+9% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $5.25T+10% | SEC ↗ |
| Q1 2025 | May 2, 2025 | $4.76T−4% | SEC ↗ |
| Q4 2024 | Feb 7, 2025 | $4.94T+4% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $4.76T+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $4.42T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $4.30T+10% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $3.92T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $3.48T−4% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $3.63T+7% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $3.39T+6% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $3.19T+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $2.94T−6% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.12T−16% | SEC ↗ |
| Q1 2022 | May 12, 2022 | $3.71T−6% | SEC ↗ |
| Q4 2021 | Feb 10, 2022 (amended) | $3.93T+10% | SEC ↗ |
| Q3 2021 | Nov 9, 2021 | $3.57T−1% | SEC ↗ |
| Q2 2021 | Aug 11, 2021 | $3.59T+6% | SEC ↗ |
| Q1 2021 | May 7, 2021 | $3.40T+9% | SEC ↗ |
| Q4 2020 | Feb 5, 2021 | $3.13T+16% | SEC ↗ |
| Q3 2020 | Nov 6, 2020 | $2.71T+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.51T+23% | SEC ↗ |
| Q1 2020 | May 1, 2020 | $2.04T−22% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $2.61T+10% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $2.38T+2% | SEC ↗ |
| Q2 2019 | Aug 22, 2019 (amended) | $2.34T+4% | SEC ↗ |
| Q1 2019 | May 9, 2019 | $2.24T+13% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.98T−14% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $2.31T+6% | SEC ↗ |
| Q2 2018 | Aug 9, 2018 | $2.17T+4% | SEC ↗ |
| Q1 2018 | May 9, 2018 | $2.09T−0% | SEC ↗ |
| Q4 2017 | Feb 9, 2018 | $2.10T+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.98T+5% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.89T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.82T+2,478% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $70.66B+1% | SEC ↗ |
| Q3 2016 | Nov 8, 2016 | $69.66B+5% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $66.46B+7% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $62.17B | SEC ↗ |